The names on this page are hidden. Create a free account to reveal 5 records a month, or get Private Credit Intelligence at $249 a month for every name. Every figure, date and source on this page is public either way.

Borrower

N••••• L••••••••• I••

Pharmaceuticals, Biotechnology & Life Sciencesgroup grade Aon a schedule nowsponsor unattributed
Principal held
at least $8.5M
sum of BDC pieces, a lower bound
Fair value
$8.6M
104c on cost, debt pieces
Unfunded
n/a
commitments not yet drawn
BDC lenders
1
1 on the latest quarter
Facilities
1
1 equity pieces beside them
Next maturity
Apr 14, 2027
$8.5M inside 24 months
On the tape since
Jun 30, 2026
latest Jun 30, 2026
Events
4
dated, non-routine
Capital structure as the BDCs see it
latest quarter end Jun 30, 2026
FacilityHeldOn costPricingMaturityBDCs
first lien term loan first lienat least $8.5M104cSOFR+900 bpApr 14, 20271
Equity pieces beside the debt: preferred equity ($23,000 fair value, 1 BDC)
Lenders
every BDC piece at the latest quarter end
BDCInstrumentPrincipalFair valueRate
R••••• G••••• F•••••• C••••preferred equity equity
W••••••• & O•••• C••••••••• R••••• Investment T••• W•••••• S••••• A-3 P•••••••• S•••• I•••
n/a$1,000
5c
R••••• G••••• F•••••• C••••preferred equity equity
W••••••• & O•••• C••••••••• R••••• Investment T••• W•••••• S••••• B-1 P•••••••• S•••• I•••
n/a$22,000
14c
R••••• G••••• F•••••• C••••term loan first lien
Investment T••• S••••• S•••••• I••••••• R••• S•••+9.00% 12.75% floor 10.00% ETP A•••••••••
$8.5M$8.6M
104c
SOFR+900 bp
Through time
the borrower's pieces summed across BDCs, every quarter end
Quarter endBDCsPrincipal heldFair valueOn costPIK pieces
Jun 30, 20261$8.5M$8.6M104c0
What changed
Every change including routine ones
Identity
Group key
N••••• L•••••••••derivedthe codename stem after legal suffixes and deal words
Spellings
1 across 1 BDCderived
Industry
Pharmaceuticals, Biotechnology & Life Sciencesreportedas one filer wrote it